These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 20083551
1. Candida spp. bloodstream infection: influence of antifungal treatment on outcome. Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Pitart C, Mensa J. J Antimicrob Chemother; 2010 Mar; 65(3):562-8. PubMed ID: 20083551 [Abstract] [Full Text] [Related]
5. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B. J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778 [Abstract] [Full Text] [Related]
10. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. J Antimicrob Chemother; 2007 Sep 15; 60(3):613-8. PubMed ID: 17576697 [Abstract] [Full Text] [Related]
11. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors. Boo TW, O'reilly B, O'leary J, Cryan B. Mycoses; 2005 Jul 15; 48(4):251-9. PubMed ID: 15982207 [Abstract] [Full Text] [Related]
12. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Medicine (Baltimore); 2003 Sep 15; 82(5):309-21. PubMed ID: 14530780 [Abstract] [Full Text] [Related]
13. Candida glabrata fungaemia in intensive care units. Ruan SY, Lee LN, Jerng JS, Yu CJ, Hsueh PR. Clin Microbiol Infect; 2008 Feb 15; 14(2):136-40. PubMed ID: 18042196 [Abstract] [Full Text] [Related]
14. Treatment options in candidaemia. Karthaus M, Cornely OA. Mycoses; 2007 Feb 15; 50 Suppl 1():44-9. PubMed ID: 17394609 [Abstract] [Full Text] [Related]
15. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group. Crit Care Med; 2009 May 15; 37(5):1612-8. PubMed ID: 19325476 [Abstract] [Full Text] [Related]
16. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C. J Antimicrob Chemother; 2009 Sep 15; 64(3):625-9. PubMed ID: 19622536 [Abstract] [Full Text] [Related]
17. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Morrell M, Fraser VJ, Kollef MH. Antimicrob Agents Chemother; 2005 Sep 15; 49(9):3640-5. PubMed ID: 16127033 [Abstract] [Full Text] [Related]